Indian J Ophthalmol. 2010 Jan-Feb;58(1):70-3.

Intravitreal cysticercosis presenting as neovascular glaucoma.

Ratra D, Phogat C, Singh M, Choudhari NS.

Source

Bhagawan Mahavir Vitreoretinal Services and Department of Glaucoma, Sankara Nethralaya, Chennai, India.

Abstract

We report two cases of intraocular cysticercosis which showed a peculiar presentation of neovascular glaucoma which is hitherto unreported. Two young adults presented with symptoms of raised intraocular pressure due to neovascular glaucoma. On dilated fundus examination both were found to have dead intravitreal cysticercosis. The cysts were removed by a three-port vitrectomy and intracameral injection of bevacizumab was given to help in the regression of rubeosis. Trabeculectomy had to be combined in one case. The intraocular pressure returned to normal. No recurrence of rubeosis was seen even after one year.

PMID:: 20029152; [PubMed - indexed for MEDLINE]
PMCID:: PMC2841380

Free PMC Article

Images from this publication.See all images (5) Free text

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Eye Infections - MedlinePlus Health Information

Supplemental Content

Icon for Medknow Publications and Media Pvt Ltd

Save items

Related citations in PubMed

Management of intra-vitreal cysticercosis. [Nepal J Ophthalmol. 2009]
Management of intra-vitreal cysticercosis.
Yadav SK, Winter I, Singh SK. Nepal J Ophthalmol. 2009 Jul-Dec; 1(2):143-5.
Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome. [Korean J Ophthalmol. 2009]
Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome.
Lee SJ, Lee JJ, Kim SY, Kim SD. Korean J Ophthalmol. 2009 Jun; 23(2):132-4. Epub 2009 Jun 9.
Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma. [Eur J Ophthalmol. 2009]
Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
Hasanreisoglu M, Weinberger D, Mimouni K, Luski M, Bourla D, Kramer M, Robinson A, Axer-Siegel R. Eur J Ophthalmol. 2009 Jul-Aug; 19(4):607-12.
Review Medical and surgical treatment of neovascular glaucoma. [Int Ophthalmol Clin. 2011]
Review Medical and surgical treatment of neovascular glaucoma.
Olmos LC, Lee RK. Int Ophthalmol Clin. 2011 Summer; 51(3):27-36.
Review [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery]. [Ophthalmologe. 2009]
Review [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery].
Lüke J, Lüke M, Grisanti S. Ophthalmologe. 2009 May; 106(5):407-12.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Intravitreal cysticercosis presenting as neovascular glaucoma.
Intravitreal cysticercosis presenting as neovascular glaucoma.
Indian J Ophthalmol. 2010 Jan-Feb ;58(1):70-3.

PubMed
The ID23-2 structural biology microfocus beamline at the ESRF.
The ID23-2 structural biology microfocus beamline at the ESRF.
J Synchrotron Radiat. 2010 Jan ;17(1):107-18. Epub 2009 Dec 5 .

PubMed
Reconsidering the asymptotic null distribution of likelihood ratio tests for gen...
Reconsidering the asymptotic null distribution of likelihood ratio tests for genetic linkage in multivariate variance components models under complete pleiotropy.
Biostatistics. 2010 Apr ;11(2):226-41. Epub 2009 Dec 22 .

PubMed
Reduction of Raf kinase inhibitor protein expression by Bcr-Abl contributes to c...
Reduction of Raf kinase inhibitor protein expression by Bcr-Abl contributes to chronic myelogenous leukemia proliferation.
J Biol Chem. 2010 Feb 26 ;285(9):6585-94. Epub 2009 Dec 22 .

PubMed
Emerging role of neuregulin as a modulator of muscle metabolism.
Emerging role of neuregulin as a modulator of muscle metabolism.
Am J Physiol Endocrinol Metab. 2010 Apr ;298(4):E742-50. Epub 2009 Dec 22 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: